Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
AstraZeneca
McKinsey
Farmers Insurance
Moodys
QuintilesIMS

Generated: September 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,198,858

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,198,858 protect, and when does it expire?

Patent 9,198,858 protects NUVESSA and is included in one NDA.

This patent has thirteen patent family members in eight countries.

Summary for Patent: 9,198,858
Title:Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations
Abstract: The present disclosure provides mucoadhesive aqueous-based gel formulations of metronidazole useful for a variety of purposes, including intravaginal application as a therapeutic approach towards the treatment of individuals suffering from and/or diagnosed with bacterial vaginosis.
Inventor(s): Nordsiek; Michael T. (Wayne, PA), Balaji; Kodumudi S. (Landsdale, PA)
Assignee: Watson Pharmaceuticals, Inc. (Salt Lake City, UT)
Application Number:13/593,386
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 9,198,858

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chemo Research Sl NUVESSA metronidazole GEL;VAGINAL 205223-001 Mar 24, 2014 RX Yes Yes   Try a Free Trial   Try a Free Trial TREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,198,858

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012275292   Try a Free Trial
Australia 2016200825   Try a Free Trial
Brazil 112013033759   Try a Free Trial
Canada 2840571   Try a Free Trial
China 103763925   Try a Free Trial
China 107823123   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Mallinckrodt
McKinsey
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.